Pine Labs Q1 FY27 net profit drops 67% QoQ to ₹19.57 crore despite revenue rise
Synopsis
Pine Labs posted a 67% sequential drop in net profit to ₹19.57 crore in Q1 FY27 as expenses outpaced revenue, even as year-on-year profit surged more than fourfold. With the stock already down nearly 35% year-to-date since its November 2025 listing, the cost-control question is now central to any recovery thesis.
Key Takeaways
Pine Labs reported a 67% quarter-on-quarter fall in consolidated net profit to ₹19.57 crore in Q1 FY27 (April–June 2025).
On a year-on-year basis, net profit rose more than fourfold from ₹4.79 crore in the same quarter last year.
Revenue from operations grew to ₹736.92 crore , up sequentially from ₹700.51 crore and year-on-year from ₹615.91 crore .
Total expenses rose to ₹728.14 crore , outpacing sequential revenue growth and compressing margins.
The stock has fallen 34.95% year-to-date on the BSE , sharply underperforming the Sensex since its November 2025 listing.
Fintech company Pine Labs on Tuesday, 28 July 2025, reported a 67 per cent quarter-on-quarter decline in consolidated net profit to ₹19.57 crore for the first quarter of FY27 (April–June 2025), even as revenue from operations continued to grow sequentially. The sharp sequential profit drop comes despite the company posting a more-than-fourfold improvement in net profit on a year-on-year basis.
Profit and Revenue at a Glance
Pine Labs had posted a consolidated net profit of ₹59.36 crore in the January–March quarter of FY26, making the sequential decline stark. However, on a year-on-year basis, net profit surged from just ₹4.79 crore in the corresponding quarter of the previous fiscal — a sign that the underlying business has strengthened considerably over twelve months.
Revenue from operations climbed to ₹736.92 crore in Q1 FY27, up from ₹700.51 crore in the preceding quarter and ₹615.91 crore in the year-ago period. Total income for the quarter stood at ₹765.87 crore, compared with ₹741.44 crore in Q4 FY26 and ₹653.08 crore a year earlier.
Rising Expenses Weigh on Margins
Total expenses rose to ₹728.14 crore during the quarter, up from ₹681.92 crore in the previous quarter and ₹657.86 crore a year earlier. The cost increase outpaced revenue growth on a sequential basis, compressing profitability.
Profit before tax (PBT) came in at ₹31.73 crore for the April–June quarter, down sharply from ₹68.41 crore in Q4 FY26, though well ahead of the ₹4.84 crore recorded in the year-ago period. A tax expense of ₹12.16 crore during the quarter resulted in the reported net profit of ₹19.57 crore.
Stock Performance and Market Reaction
Shares of Pine Labs settled 1.18 per cent higher at ₹153 per share on the BSE on Tuesday, even as the results revealed the sequential profit squeeze. The modest gain, however, masks a prolonged period of underperformance since the company's stock market listing in November 2025.
The stock has shed 25.58 per cent over the past three months, 33.61 per cent over six months, and 34.95 per cent year-to-date — a stark contrast to the benchmark Sensex, which declined 0.16 per cent, 6.77 per cent, and 9.89 per cent over the same periods respectively.
What to Watch
The divergence between Pine Labs' improving year-on-year trajectory and its sequential profit compression will be closely watched by analysts in the quarters ahead. The key question is whether the company can rein in expense growth while sustaining revenue momentum — a balancing act that will determine whether the stock can recover lost ground since its listing.
Point of View
Not a revenue one — the top line is growing, but expenses are growing faster. That is a classic post-listing pressure pattern: companies ramp spending to sustain growth narratives while public market scrutiny tightens. The year-on-year improvement is real but risks being overshadowed if the expense trajectory does not flatten in Q2. With the stock already down 35% year-to-date and well below its listing price, management credibility on margin guidance will matter more than any single quarter's revenue beat.
NationPress
28 Jul 2026
Frequently Asked Questions
What was Pine Labs' net profit in Q1 FY27?
Pine Labs reported a consolidated net profit of ₹19.57 crore in Q1 FY27 (April–June 2025), a 67 per cent decline from ₹59.36 crore in the preceding January–March quarter of FY26. On a year-on-year basis, however, profit rose more than fourfold from ₹4.79 crore.
Why did Pine Labs' profit fall so sharply quarter-on-quarter?
The sequential profit decline was driven primarily by a rise in total expenses to ₹728.14 crore in Q1 FY27 from ₹681.92 crore in the previous quarter, which outpaced sequential revenue growth. Profit before tax fell to ₹31.73 crore from ₹68.41 crore in Q4 FY26.
How did Pine Labs' revenue perform in Q1 FY27?
Revenue from operations rose to ₹736.92 crore in Q1 FY27, up from ₹700.51 crore in Q4 FY26 and ₹615.91 crore in the year-ago period, reflecting continued sequential and year-on-year growth.
How has Pine Labs' stock performed since its listing?
Pine Labs shares have significantly underperformed since their listing in November 2025, falling 34.95 per cent year-to-date, 33.61 per cent over six months, and 25.58 per cent over three months on the BSE — compared with Sensex declines of 9.89 per cent, 6.77 per cent, and 0.16 per cent over the same periods.
What is Pine Labs' tax expense for Q1 FY27?
Pine Labs recorded a tax expense of ₹12.16 crore during Q1 FY27, which, applied against a profit before tax of ₹31.73 crore, yielded the reported consolidated net profit of ₹19.57 crore.
